Pension promises hurt BT - time to sell?

Against a background of political posturing, The Colonel worries that pensions could pose serious problems for one of his portfolio stalwarts

Share Sleuth: the 'value' share I have been buying

Richard Beddard has trimmed his holding in cyclical winner Trifast to buy temptingly priced Portmeirion

Share Sleuth: a valuation measure investors can trust

Look at the whole business, including debt, for a clearer view of valuation, advises Richard Beddard.

Trusts with a war chest of cash can weather stock market storms

Markets have stormed ahead in 2017, but the formal countdown to Brexit puts the security of equity income firmly in the spotlight.

Quantitative easing’s good times are over; it’s time to prepare

We may be best advised to get set for the lows after the highs of the QE sugar rush, suggests Andrew Pitts as he deploys his portfolio’s cash holding to buy inflation-linked bonds.

10 long-term holds for an Isa portfolio: part one

In the first of a two-part series, analyst Richard Beddard names five great companies to use up your Isa allowance. Part 2 next week.

Share Sleuth: how to make the price/earnings ratio more useful

Price/earnings ratio, when expressed as earnings yield, means you can compare shares with returns on assets such as bonds and cash.

The 'Trump rally' will fade, but this will create buying opportunities

Investors enjoyed the fruits of exuberant market performance in 2016 despite emergent political risks, but they face great uncertainty in 2017.

Share Watch: Britvic, Dewhurst, Future, ITE and Treatt

Britvic and other soft drinks manufacturers may be following tobacco, gambling and alcohol firms into the sin stock category, says Richard Beddard.

Share Sleuth: why 'skin in the game' is important

It would be good for shareholders if bosses held shares for the long term in the firms they run, says Richard Beddard